Aegerion Pharmaceuticals (AEGR) was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the …
marking the fourth consecutive day the stock has increased. Some of the biggest losers among healthcare stocks include: Aegerion Pharmaceuticals (AEGR): AEGR stock is down 21.6% today on 8 times normal volume. Acadia Healthcare …
but if investors have been misled and the number is actually 90% less, what will we value AEGR's stock price with a U.S. patient population of only 300? Here is a claim made in the third quarter conference call: "… I would emphasize that …
Aegerion /quotes/zigman/624094/delayed /quotes/nls/aegr AEGR shares climbed back up Monday by 16% to $81.65 after last week’s tumble, instantly putting the company’s stock back into the low-$80 range from the low-$70 level that it …
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) engages in the development and commercialization ... Aegerion closed Monday at $56.74. The stock is down more than 20% since the beginning of the year. Best Buy Co. Inc. (NYSE: BBY) …
Vbi Vaccines Inc (VBIV): VBIV stock is up 9.62% today. Impax Laboratories (IPXL): IPXL stock is up 9.39% today. Aegerion Pharmaceuticals (AEGR): AEGR stock is up 9.04% today. Tonix Pharm Hldg Cor (TNXP): TNXP stock is up …
One name in particular that got drilled viciously was Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). The company posted a huge earnings miss and offered less than stellar guidance. To make things worse, the company’s stock was …
Aegerion Pharmaceuticals (AEGR) is a classic example of a much hyped biotech failing to deliver on its promise. In 2013, the company promised a great deal as its lead product candidate was approved by the FDA. That year saw the stock …
(Editor’s note: Corrected to show Chimerix’s stock offering involves existing shares ... It was unclear what drove the drop for Aegerion /quotes/zigman/624094 /quotes/nls/aegr AEGR, which plunged more than 10% to $76.42 at the close.
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) should have a slogan that says “We love volatility.” The biotech stock now trades for just under $60 after its earnings report, but the 52-week trading range is $29.61 to $101.00. After a poor …